Table 2.
Baseline variables at trial entry. Figures are numbers (percentages) of women unless stated otherwise
| Misoprostal (n=365) | Dinoprostone (n=376) | |
|---|---|---|
| Mean (SD) age (years)* | 27.9 (5.6) | 28.0 (5.6) |
| Nulliparous | 213 (58.4) | 221 (58.8) |
| White | 355 (97.3) | 362 (96.3) |
| Public patient | 362 (99.2) | 376 (100.0) |
| Indication for induction of labour: | ||
| After due date | 181 (49.6) | 175 (46.5) |
| Pre-eclampsia | 30 (8.2) | 37 (9.8) |
| Hypertension | 49 (13.4) | 55 (14.6) |
| Intrauterine growth restriction | 24 (6.6) | 32 (8.5) |
| Abnormal glucose tolerance | 29 (8.0) | 46 (12.2) |
| Social | 55 (15.1) | 46 (12.2) |
| Other | 21 (5.8) | 25 (6.6) |
| Initial Bishop score: | ||
| 0-3 | 246 (67.4) | 214 (56.9) |
| 4-6 | 119 (32.6) | 162 (43.1) |
| Mean (SD) gestational age (weeks)* | 40.6 (2.0) | 40.4 (2.1) |
| Mean (SD) height (m)* | 165.1 (5.8) | 165.0 (6.6) |
| Median (IQR) weight at booking (kg) | 72.0 (48.0-96.0) | 75.0 (49.0-101.0) |
| BMI >30 (kg/m2) at booking | 94 (34.0) | 98 (33.1) |
| Smoking at booking | 84 (23.0) | 86 (22.9) |
IQR=interquartile range; BMI=body mass index.